WeVote
Log In

Bill

Bill

S 907

Relates to leaving the scene of an incident without reporting

2025 Regular Session Introduced by George Borrello and 5 co-sponsors

Directs DPH to reissue license 2114 for Norwood Performance Therapy and related facilities, preserving life-saving treatments (chemo, radiation) with immediate emergency effect.

REFERRED TO TRANSPORTATION
0
WeVote Research Nonpartisan
Bill Summary · S 907

Summary — S. 907 (2025): "An Act to protect Norwood healthcare access"

Note: The materials provided include multiple, inconsistent documents. This summary focuses on the Massachusetts bill text titled “An Act to protect Norwood healthcare access” (Senate Docket No. 1042 / Senate No. 907), introduced by Senator Michael F. Rush, which contains a clear substantive provision. Other text in the packet (New Jersey medical cannabis provisions, unrelated federal/state sponsor lists) appears to be unrelated to this Massachusetts measure.

Purpose

To preserve continuity of health care services in Norwood by directing the Massachusetts Department of Public Health (DPH) to reissue a specific department license (No. 2114) so that the provider(s) operating under that license can continue to deliver critical treatments (including chemotherapy, radiation, radiology, and other therapies and studies).

The bill is enacted as an emergency measure to take immediate effect for the protection of public health.

Key provisions

  • Notwithstanding any general or special law, or any provision of Chapter 111 of the Massachusetts General Laws or regulations thereunder, the Department of Public Health is authorized and directed to reissue department license number 2114.
  • The license to be reissued is identified as having been issued on November 6, 2022.
  • The statutory reissuance is expressly to maintain the provision of health care services provided, as of the date of the act, to the facility identified as 22LD, known as Norwood Performance Therapy.
  • The directive also covers “any other such facilities operating under said license number 2114 that is not currently under any other license issued by the department of public health.”
  • The act is declared an emergency law, effective immediately upon enactment.

Who would be affected

  • Primary: Norwood Performance Therapy (facility identified as 22LD) and any other facilities currently operating under license No. 2114 that lack another DPH license.
  • Patients receiving life‑saving and essential treatments at these facilities (e.g., chemotherapy, radiation, radiology).
  • Department of Public Health (responsible for reissuing the license and implementing the directive).
  • Health care staff and affiliated providers at the affected facilities.
  • Potentially insurers and referral partners who rely on the facility’s licensure status.

Procedural/timeline notes

  • Bill filed/presented in the Massachusetts Senate (Senate Docket No. 1042 / Senate No. 907) by Michael F. Rush; filed 1/15/2025.
  • The bill text declares it an emergency law (immediate effective date upon enactment).
  • A hearing was scheduled for 06/18/2025 (11:00 AM–3:00 PM) in Gardner Auditorium, per the provided actions list.

Potential effects and considerations

  • Immediate continuity of care: Reissuing the license would avoid disruption of time‑sensitive treatments (e.g., chemotherapy, radiation) for patients served by the facility.
  • Regulatory and oversight implications: An explicit statutory reissuance “notwithstanding” existing laws or regulations is an exception to normal licensing processes; it may raise questions about precedent, conditions attached to reissuance, and oversight/accountability of the facility going forward.
  • Limited scope: The bill is narrowly targeted to a named license (No. 2114) and specified facility(ies); it does not create a general licensing rule.
  • Budgetary impact: The bill does not specify funding; reissuance is an administrative action by DPH and likely imposes minimal direct fiscal impact on the Commonwealth, though DPH administrative costs are possible.

Additional note on document inconsistencies

The packet also includes unrelated legislative text concerning New Jersey medical cannabis business development and a disparate list of sponsors and related bills from other jurisdictions. Those materials are not part of the Massachusetts S.907 bill described above and were not relied upon in preparing this summary. If you want summaries of those other items, please provide clarification about which specific bill(s) to analyze.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.